Catheter Ablation Beats Drug Therapy in Atrial Fibrillation Patients With Lower Risk Factors: CABANA Subanalysis
China: A new secondary analysis of the Catheter Ablation vs Anti-Arrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial suggests that the benefit of catheter ablation over drug therapy in atrial fibrillation (AF) largely depends on the patient’s burden of non-modifiable recurrence risk factors (NMRRFs). The study, led by Zhen Wang and colleagues from the Department […]